Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121158 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 167
- Enrollment target
NCT02121158: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT02121158 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 167 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02121158, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
Study Summary
The overall aim of this trial is to study the safety and efficacy of ICD implantation as a primary prevention strategy of sudden cardiac death in patients 70 years and older. This study will assess the many competing factors involved with ICD implantation including 1) the impact on mortality, especially in the context of a declining rate of sudden death with advanced age, 2) the tolerability of the powerful therapeutic action of the device, and 3) the impact on quality of life.
Primary Outcome
All-cause mortality
Interventions
- DEVICE Implantable Cardioverter Defibrillator
- OTHER Optimal Medical Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2015-08-07 |
| Est. Completion | 2020-11-06 |
| Phase | NA |
Why NCT02121158 stopped before completion
NCT02121158 is an interventional study that assigns participants to a tested intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Implantable Cardioverter Defibrillator is the first listed.
NCT02121158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02121158 about?
NCT02121158 is a clinical study titled "Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly". The overall aim of this trial is to study the safety and efficacy of ICD implantation as a primary prevention strategy of sudden cardiac death in patients 70 years and older. This study will assess the many competing factors involved with ICD implantation including 1) the impact on mortality, especi...
What is the current status of trial NCT02121158?
This trial is currently terminated. It is a NA study. The enrollment target is 167 participants. The study started on 2015-08-07. Estimated completion is 2020-11-06.
What interventions are being tested in trial NCT02121158?
The interventions under investigation include: Implantable Cardioverter Defibrillator (DEVICE), Optimal Medical Therapy (OTHER).
Who is sponsoring clinical trial NCT02121158?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02121158's enrollment target sits among peer trials
167 622nd of 2000 higher than 1,376 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI